Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00072709 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

551

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: TCH346

Sponsor

Novartis Pharmaceuticals